Liver Diseases  >>  Incivek (telaprevir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
NCT01415141: Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Withdrawn
4
0
US
Peginterferon alfa-2a, Ribavirin, telaprevir
University of Vermont
Hepatitis C
07/11
07/11
NCT01766115: Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers

Withdrawn
4
0
US
Telaprevir, Incivek
Massachusetts General Hospital
Viral Hepatitis C
05/14
05/14
NCT01592006: Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Terminated
4
3
US
Peginterferon alfa-2a, Ribavirin, telaprevir
University of Chicago
Hepatitis C
09/14
09/14
DARE-C, NCT01743521: DAA Based Therapy for Recently Acquired Hepatitis C

Completed
4
14
RoW
TPV/PEG-IFN/RBV, Telaprevir brand name: INCIVO, Ribavirin brand name: COPEGUS, PEG-IFN brand name: PEGASYS
Kirby Institute, Janssen-Cilag Ltd.
Hepatitis C, Chronic
11/15
01/16

Download Options